BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,511,000 | -59.0% | 50,000 | -46.2% | 0.35% | -70.8% |
| Q3 2022 | $6,128,000 | -6.7% | 93,000 | -28.5% | 1.19% | -11.9% |
| Q2 2022 | $6,566,000 | -32.8% | 130,000 | -15.0% | 1.35% | -46.9% |
| Q1 2022 | $9,774,000 | +21.7% | 153,000 | +104.0% | 2.54% | +14.4% |
| Q4 2021 | $8,033,000 | -20.3% | 75,000 | -23.5% | 2.22% | -23.2% |
| Q3 2021 | $10,075,000 | +14.5% | 98,000 | -2.0% | 2.90% | +19.6% |
| Q2 2021 | $8,796,000 | -23.0% | 100,000 | -14.9% | 2.42% | -25.8% |
| Q1 2021 | $11,425,000 | +19.8% | 117,500 | +38.2% | 3.26% | +15.1% |
| Q4 2020 | $9,533,000 | -2.1% | 85,000 | -19.0% | 2.84% | -4.8% |
| Q3 2020 | $9,734,000 | +13.4% | 105,000 | -4.5% | 2.98% | +15.9% |
| Q2 2020 | $8,580,000 | +144.5% | 110,000 | +83.3% | 2.57% | +66.2% |
| Q1 2020 | $3,509,000 | +119.0% | 60,000 | +200.0% | 1.55% | +147.8% |
| Q4 2019 | $1,602,000 | – | 20,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |